Prevalence and factors associated with polypharmacy in schizophrenia
- Conditions
- Health Condition 1: F200- Paranoid schizophrenia
- Registration Number
- CTRI/2024/06/068694
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients with primary diagnosis of schizophrenia as per ICD- 11
2. Patients on follow up for at least 6 months
3. Patients/ Nominated representative willing to give written informed consent
4. Patients accompanied by a reliable informant
5. Patients between 18-65 years of age
6. Any gender
1. Patients already diagnosed with co-morbid psychiatric disorder such as anxiety disorders, depressive disorders, obsessive compulsive disorders, mood disorders and organic disorders.
2. Uncooperative, violent and actively suicidal patients.
3. Persons with co-morbid substance dependence except nicotine and caffeine.
4. Patients with co-morbid Intellectual disability, Alzheimer’s disease, dementia and other neurodegenerative disorders.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method